Company intelligence

CLBT

Cellebrite DI Ltd. · NASDAQ · Technology

Price$11.07-0.63% · −$0.07

Market cap2.76BEquity value

P / E47.6Trailing ratio

Volume2.05MLatest session

Market data

CLBT price chart

TradingView

Related signals

1 min delayed

Browse public CLBT signals with their source context and measured market impact. Open any signal for its permanent analysis page.

CLBTOct 2, 2026-0.61% since signal

Kaplan Fox Investigation Highlights Cellebrite CLBT Securities Risk After ARR Miss

Kaplan Fox & Kilsheimer LLP announced an investigation into potential securities violations at Cellebrite after its Q2 results showed ARR of $507.8 million and a mid-point ARR guidance cut of about $15 million. The abrupt CEO change to Shiv Ramji and a 29% stock drop heighten investor concern over Cellebrite's growth trajectory and governance, potentially weighing on CLBT near-term sentiment.

View signal analysis

CLBTMay 23, 2024-4.22% since signal

Cellebrite DI Ltd. (CLBT) Q1 Earnings and Revenues Surpass Estimates

- Cellebrite DI Ltd. beat earnings estimates with $0.08 per share, a 33.33% surprise. - Revenues for the quarter reached $89.58 million, exceeding estimates by 4.15%. - Recent stock performance saw a 34.1% increase since the beginning of the year. - Strong earnings outlook and favorable estimate revisions indicate potential outperformance. - Industry rank for Technology Services is in the top 23% of Zacks industries. Price Impact Rating: bullish Impact Horizon Rating: short-term Type: Research Analysis

View signal analysis

Research